AbbVie, J&J to add proprietary data to AI protein model in bid to accelerate drug discovery
Posted:
Life sciences data company Apheris on Thursday announced an effort to boost the capabilities of protein AI models by uniting several pharmaceutical companies’ proprietary data. Apheris’ consortium of pharma companies is partnering with OpenFold3 — Columbia professor Mohammed AlQuraishi’s open-source dupe of AlphaFold3 — to train the model on AbbVie and Johnson & Johnson’s vast stores of structural data. The collaboration will focus on structures relevant to drug discovery, such as small molecule-protein and antibody-antigen interactions.
We are pleased to welcome genedrive as a sponsor and exhibitor at this year’s GIANT Health Event.
Based in Manchester, genedrive is a diagnostics company developing rapid pharmacogenetic testing solutions designed to support safer, more effective prescribing decisions. By helping…
As healthcare systems continue to evolve, ensuring that new technologies deliver real value for patients, professionals, and the wider health and care system is more important than ever.
At GIANT Health, we are pleased to highlight our exhibitor Health Technology…
Attendees
Sponsors and Exhibitors
Contact us